Swedish health tech innovator Coala Life AB selected Innokas Medical to manufacture Coala Heart Monitor, which has global market potential.
Recent Posts
Innokas Medical continues internationalization; the company has entered into an agreement with Swedish medtech company Alcosystems AB. The agreement brought yet another Swedish customer to...
Innokas Medical and the Norwegian company Luzmon Medical AS have recently signed a manufacturing contract for the Luzmon’s cTEMS and cTENS system including some NPI and sourcing work. The...
Innokas Medical, acting today as an independent subsidiary of Serres Group, has renewed its strategy during the spring and summer. With the new strategy Innokas aims to achieve the company’s new...
Danish company RSP Systems selected Innokas Medical to develop a prototype for a non-invasive glucose monitoring device that has global market potential.
The European Commission has granted Innokas Medical almost €700 000 of funding. The funding was granted to Innokas from the Horizons 2020 Fast Track to Innovation (FTI) pilot, which provides...
Innokas Medical continues internationalization; Innokas Medical has entered into agreement with C-Rad Positioning AB. The agreement brought yet another Swedish customer to Innokas, so this serves...
Innokas Medical and the Swedish company Bonvisi AB have recently signed an R&D agreement, and shall soon sign a manufacturing contract for the Bonvisi ENDO Pump system – ENDO P® – endoscopic...
Innokas Medical continues internationalization: Innokas Medical has entered into agreements with major international customers
